Literature DB >> 7038325

Rifampin.

B Farr, G L Mandell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7038325     DOI： 10.1016/s0025-7125(16)31449-3

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


× No keyword cloud information.
  9 in total

1.  Addition of rifampicin in persistent Haemophilus influenzae type B meningitis.

Authors:  M A Lewis; B L Priestley
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

2.  Intraocular penetration of rifampin after oral administration.

Authors:  K W Wong; D J D'Amico; B S Oum; P A Baker; K R Kenyon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

3.  Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.

Authors:  M C Ramos; M Ing; E Kim; M D Witt; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1996-01       Impact factor: 5.191

4.  Uptake, intracellular activity, and influence of rifampin on normal function of polymorphonuclear leukocytes.

Authors:  P H Höger; K Vosbeck; R Seger; W H Hitzig
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

5.  Concentration of the macrolide antibiotic tulathromycin in broncho-alveolar cells is influenced by comedication of rifampicin in foals.

Authors:  Monica Venner; Jette Peters; Nina Höhensteiger; Birthe Schock; Alexa Bornhorst; Markus Grube; Ulrike Adam; Eberhard Scheuch; Werner Weitschies; Dieter Rosskopf; Heyo K Kroemer; Werner Siegmund
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-12-15       Impact factor: 3.000

6.  In vitro synergism of rifampin-cephalosporin combinations against Haemophilus influenzae type b.

Authors:  R C Gordon; R Wofford-McQueen; K Shu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-03       Impact factor: 3.267

7.  Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients.

Authors:  V L Yu; J J Zuravleff; J E Peacock; D DeHertogh; L Tashjian
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

8.  Structure-Activity Studies with Bis-Amidines That Potentiate Gram-Positive Specific Antibiotics against Gram-Negative Pathogens.

Authors:  Charlotte M J Wesseling; Cornelis J Slingerland; Shanice Veraar; Samantha Lok; Nathaniel I Martin
Journal:  ACS Infect Dis       Date:  2021-11-12       Impact factor: 5.084

9.  Thrombin-Derived Peptides Potentiate the Activity of Gram-Positive-Specific Antibiotics against Gram-Negative Bacteria.

Authors:  Charlotte M J Wesseling; Thomas M Wood; Kristine Bertheussen; Samantha Lok; Nathaniel I Martin
Journal:  Molecules       Date:  2021-03-30       Impact factor: 4.411
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.